Molecule Details
InChIKeyQDGDDAFKQVQWCI-UHFFFAOYSA-N
Compound Name4-[(2Z)-2-[(2E,4E)-5-[3,3-dimethyl-1-[6-oxo-6-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butylamino]hexyl]indol-1-ium-2-yl]penta-2,4-dienylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonate
Canonical SMILESCC1(C)C(/C=C/C=C/C=C2/N(CCCCCC(=O)NCCCCC3CCN(CC(=O)N4c5ccccc5NC(=O)c5ccccc54)CC3)c3ccccc3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccccc21
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)5
Pfam Stratification Homologous
Avg pChEMBL6.43
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
Target Activities (5)
Target Gene Organism Category Pfam pChEMBL Type Source
P08172 CHRM2 Homo sapiens Human PF00001 6.8 Ki ChEMBL;BindingDB
P08173 CHRM4 Homo sapiens Human PF00001 6.7 Ki ChEMBL;BindingDB
P11229 CHRM1 Homo sapiens Human PF00001 6.5 Ki ChEMBL;BindingDB
P08912 CHRM5 Homo sapiens Human PF00001 6.1 Ki ChEMBL;BindingDB
P20309 CHRM3 Homo sapiens Human PF00001 6.1 Ki ChEMBL;BindingDB